Quantification of change in phosphorylation of BCR‐ABL kinase and its substrates in response to Imatinib treatment in human chronic myelogenous leukemia cells

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Proteomics

• Publication date

  2006-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/pmic.200600109PMID 16858728
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A common phosphotyrosine signature for the Bcr-Abl kinase.

  2006cited by this paper
• Use of detergents to increase selectivity of immunoprecipitation of tyrosine phosphorylated peptides prior to identification by MALDI quadrupole‐TOF MS

  2006cited by this paper
• Nucleolar proteome dynamics

  2005cited by this paper
• Immunoaffinity profiling of tyrosine phosphorylation in cancer cells

  2005cited by this paper
• Quantitative Phosphoproteomics Applied to the Yeast Pheromone Signaling Pathway*S

  2005cited by this paper
• Enhancing TOF/TOF-based de novo sequencing capability for high throughput protein identification with amino acid-coded mass tagging.

  2005cited by this paper
• Global Investigation of p53-induced Apoptosis Through Quantitative Proteomic Profiling Using Comparative Amino Acid-coded Tagging*S

  2004cited by this paper
• Inhibition of the Jun N-Terminal Protein Kinase Pathway by SHIP-1, a Lipid Phosphatase That Interacts with the Adaptor Molecule Dok-3

  2004cited by this paper
• Identifying and quantifying in vivo methylation sites by heavy methyl SILAC

  2004cited by this paper
• Abl-dependent tyrosine phosphorylation of Sos-1 mediates growth-factor-induced Rac activation

  2004cited by this paper
• A Novel Proteomic Approach for Specific Identification of Tyrosine Kinase Substrates Using [13C]Tyrosine*

  2004cited by this paper
• Quantitative Cancer Proteomics: Stable Isotope Labeling with Amino Acids in Cell Culture (SILAC) as a Tool for Prostate Cancer Research*S

  2004cited by this paper
• Properties of 13C-substituted arginine in stable isotope labeling by amino acids in cell culture (SILAC).

  2003cited by this paper
• A proteomic approach for quantitation of phosphorylation using stable isotope labeling in cell culture.

  2003cited by this paper
• Profiling of tyrosine phosphorylation pathways in human cells using mass spectrometry

  2003cited by this paper
• Dok-R Binds c-Abl and Regulates Abl Kinase Activity and Mediates Cytoskeletal Reorganization*

  2003cited by this paper
• A proteomics strategy to elucidate functional protein-protein interactions applied to EGF signaling

  2003cited by this paper
• Residue-specific mass signatures for the efficient detection of protein modifications by mass spectrometry.

  2002cited by this paper
• Stable Isotope Labeling by Amino Acids in Cell Culture, SILAC, as a Simple and Accurate Approach to Expression Proteomics*

  2002cited by this paper
• SHIP1, an SH2 Domain Containing Polyinositol-5-phosphatase, Regulates Migration through Two Critical Tyrosine Residues and Forms a Novel Signaling Complex with DOK1 and CRKL*

  2001cited by this paper
• Site-specific mass tagging with stable isotopes in proteins for accurate and efficient protein identification.

  2000cited by this paper
• The phosphatidylinositol polyphosphate 5-phosphatase SHIP1 associates with the dok1 phosphoprotein in bcr-Abl transformed cells.

  2000cited by this paper
• A novel SH2-containing phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase (SHIP2) is constitutively tyrosine phosphorylated and associated with src homologous and collagen gene (SHC) in chronic myelogenous leukemia progenitor cells.

  1999cited by this paper
• Molecular Cloning and Characterization of p56 dok-2 Defines a New Family of RasGAP-binding Proteins*

  1998cited by this paper
• Identification of a second SH2-domain-containing protein closely related to the phosphatidylinositol polyphosphate 5-phosphatase SHIP.

  1997cited by this paper
• Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein, Dok.

  1997cited by this paper
• p62(dok): a constitutively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells.

  1997cited by this paper
• A 62-kilodalton tyrosine phosphoprotein constitutively present in primary chronic phase chronic myelogenous leukemia enriched lineage negative blast populations.

  1994cited by this paper
• Implicating the bcr/abl gene in the pathogenesis of Philadelphia chromosome-positive human leukemia.

  1991cited by this paper
• Oncogenes and signal transduction.

  1991cited by this paper
• Murine models for human chronic myelogenous leukemia.

  1990cited by this paper
• Signal transduction by receptors with tyrosine kinase activity.

  1990cited by this paper
• Induction of a chronic myelogenous leukemia-like syndrome in mice with v-abl and BCR/ABL.

  1990cited by this paper
• Induction of chronic myelogenous leukemia in mice by the P210bcr/abl gene of the Philadelphia chromosome.

  1990cited by this paper
• 4 Signal Transduction and Intracellular Messengers

  1989cited by this paper
• 6 Oncogene Products in the Cytoplasm: The Protein Kinases

  1989cited by this paper
• An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity.

  1984cited by this paper
• Chronic myelocytic leukemia: clonal origin in a stem cell common to the granulocyte, erythrocyte, platelet and monocyte/macrophage.

  1977cited by this paper
• A New Consistent Chromosomal Abnormality in Chronic Myelogenous Leukaemia identified by Quinacrine Fluorescence and Giemsa Staining

  1973cited by this paper
• Identification of the Philadelphia chromosome as a number 22 by quinacrine mustard fluorescence analysis.

  1970cited by this paper

• Long non-coding RNA small nucleolar RNA host gene 29 drives chronic myeloid leukemia progression via microRNA-483-3p/Casitas B-lineage Lymphoma axis-mediated activation of the phosphoinositide 3-kinase/Akt pathway

  2024cites this paper
• Regulation of Cell Cycle Progression through RB Phosphorylation by Nilotinib and AT-9283 in Human Melanoma A375P Cells

  2024cites this paper
• Importance of targeted therapies in acute myeloid leukemia

  2021cites this paper
• Introduction to DOK2 and its Potential Role in Cancer.

  2021cites this paper
• HDAC6—An Emerging Target Against Chronic Myeloid Leukemia?

  2020cites this paper
• Epidermal Growth Factor Receptor and Abl2 Kinase Regulate Distinct Steps of Human Papillomavirus 16 Endocytosis

  2020cites this paper
• Stable Isotope Labeling by Amino Acids in Cell Culture (SILAC) for Quantitative Proteomics.

  2019cites this paper
• Identification of the Direct Substrates of the ABL Kinase via Kinase Assay Linked Phosphoproteomics with Multiple Drug Treatments.

  2019cites this paper
• The role of DOK7 and its variants in colorectal cancer

  2017cites this paper
• Title Imatinib-dependent tyrosine phosphorylation profiling of Bcr-Abl-positive chronic myeloid leukemia cells

  2017cites this paper
• Analysis of Tyrosine Kinase Signaling in Human Cancer by Stable Isotope Labeling with Heavy Amino Acids in Mouse Xenografts Utilizing Mouse Express ® Lysine 13 C 6 Mouse Feed

  2016cites this paper
• PF-114, a Novel Inhibitor of Bcr-Abl Chimeric Tyrosine Kinase, Attenuates Intracellular CrkL Phosphorylation and Kills Chronic Myeloid Leukemia Cells

  2016cites this paper
• The downregulation of BAP1 expression by BCR-ABL reduces the stability of BRCA1 in chronic myeloid leukemia.

  2015cites this paper
• Proteome Changes Induced by Imatinib and Novel Imatinib Derivatives in K562 Human Chronic Myeloid Leukemia Cells

  2014cites this paper
• Phosphorylated SHIP2 on Y1135 localizes at focal adhesions and at the mitotic spindle in cancer cell lines.

  2014cites this paper
• Stable isotope labeling by amino acids in cell culture (SILAC) for quantitative proteomics.

  2014cites this paper
• [Analysis of oncogenic signaling induced by tyrosine kinases in tumors by SILAC-based quantitative proteomic approach].

  2014cites this paper
• Broader implications of SILAC-based proteomics for dissecting signaling dynamics in cancer

  2014cites this paper
• Imatinib-dependent tyrosine phosphorylation profiling of Bcr-Abl-positive chronic myeloid leukemia cells

  2013cites this paper
• Quantitative mass spectrometry for colorectal cancer proteomics

  2013cites this paper
• Chinese a Nti鄄 Cancer a Ssociation

  2013cites this paper
• Two-Dimensional Difference Gel Electrophoresis

  2013cites this paper
• pathway in hematopoietic cells Small-molecule agonists of SHIP1 inhibit the phosphoinositide 3-kinase

  2013cites this paper
• protein stability in imatinib resistant chronic myelogenous leukemia cells Lyn regulates BCR-ABL and Gab2 tyrosine phosphorylation and c-Cbl

  2013cites this paper
• Chemical proteomics: terra incognita for novel drug target profiling

  2012cites this paper
• Proteomics approaches for myeloid leukemia drug discovery

  2012cites this paper
• Mass spectrometry approaches to monitor protein-drug interactions.

  2012cites this paper
• Chemoproteomic approaches to drug target identification and drug profiling.

  2012cites this paper
• Analysis of SRC Oncogenic Signaling in Colorectal Cancer by Stable Isotope Labeling with Heavy Amino Acids in Mouse Xenografts*

  2012cites this paper
• Substrate specificity of receptor tyrosine kinases is critical for selective signaling

  2012cites this paper
• Mass spectrometry-based chemoproteomic approaches.

  2012cites this paper
• Tyrosine kinase chromosomal translocations mediate distinct and overlapping gene regulation events

  2011cites this paper
• Imatinib Mesylate Therapy Induces Reduction in Neutrophil Gelatinase-Associated Lipocalin Serum Levels and Increase in Leptin Concentrations in Chronic Myeloid Leukemia Patients in Molecular Remission

  2011cites this paper
• Gene Expression Differences between Enriched Normal and Chronic Myelogenous Leukemia Quiescent Stem/Progenitor Cells and Correlations with Biological Abnormalities

  2011cites this paper
• Clinical proteomics of myeloid leukemia

  2010cites this paper
• Global proteome quantification for discovering imatinib-induced perturbation of multiple biological pathways in K562 human chronic myeloid leukemia cells.

  2010cites this paper
• Proteomic analysis of lymphoid and haematopoietic neoplasms: there's more than biomarker discovery.

  2010cites this paper
• Application of chemistry-based functional proteomics to screening for novel drug targets.

  2010cites this paper
• Quantitative proteome and phosphoproteome analyses of cultured cells based on SILAC labeling without requirement of serum dialysis.

  2010cites this paper
• Aptamer microarray mediated capture and mass spectrometry identification of biomarker in serum samples.

  2010cites this paper
• Functional proteomics of Bcr-Abl signaling

  2009cites this paper
• Quantitative phosphoproteomics reveals a cluster of tyrosine kinases that mediates SRC invasive activity in advanced colon carcinoma cells.

  2009cites this paper
• Survival of monocytes and macrophages and their role in health and disease.

  2009cites this paper
• Revealing promiscuous drug-target interactions by chemical proteomics.

  2009cites this paper
• [Proteomic analysis of cancer cells].

  2009cites this paper
• Activation of SHIP via a small molecule agonist kills multiple myeloma cells.

  2009cites this paper
• mediates Src invasive activity in advanced colon carcinoma cells.

  2009cites this paper
• Use of Proteomics Analysis for Molecular Precision Approaches in Cancer Therapy

  2008cites this paper
• Lyn regulates BCR-ABL and Gab2 tyrosine phosphorylation and c-Cbl protein stability in imatinib-resistant chronic myelogenous leukemia cells.

  2008cites this paper
• Small-molecule agonists of SHIP1 inhibit the phosphoinositide 3-kinase pathway in hematopoietic cells.

  2007cites this paper
• Imatinib decreases endometrial stromal cell transmesothial migration and proliferation in the extracellular matrix of modeled peritoneum.

  2007cites this paper
• Quantitative analysis with modern bioanalytical mass spectrometry and stable isotope labeling

  2007cites this paper
• Quantitative comparison of IMAC and TiO2 surfaces used in the study of regulated, dynamic protein phosphorylation

  2007cites this paper
• Protein tyrosine kinase-substrate interactions.

  2006cites this paper